In acute mania, the therapeutic serum level of lithium includes
**Question:** In acute mania, the therapeutic serum level of lithium includes
A. 0.4-0.6 mmol/L
B. 0.3-0.4 mmol/L
C. 0.8-1.2 mmol/L
D. 1.0-1.5 mmol/L
**Correct Answer:** .
**Core Concept:** Lithium is a mood stabilizer primarily used in the treatment of bipolar disorder, particularly in manic episodes. It works by modulating various neurotransmitter systems, including inhibiting glycogen synthase kinase-3 (GSK-3), enhancing brain-derived neurotrophic factor (BDNF) expression, and altering intracellular signaling pathways. The therapeutic serum level of lithium is crucial for its effectiveness and minimizing side effects.
**Why the Correct Answer is Right:** The therapeutic range for lithium in acute mania is generally considered to be 0.4-0.6 mmol/L. Maintaining this range ensures optimal therapeutic effects, such as stabilizing mood, reducing suicidal ideation, and preventing mood swings. Exceeding the therapeutic range may lead to toxicity, while falling short may not achieve the desired therapeutic effects.
**Why Each Wrong Option is Incorrect:**
A. 0.3-0.4 mmol/L (lower range) - Lithium toxicity may occur at concentrations below 0.4 mmol/L, especially if the patient is not adequately hydrated.
B. 0.8-1.2 mmol/L (upper range) - Lithium toxicity is more likely to occur at concentrations above 1.2 mmol/L, with serious complications such as nephrogenic diabetes insipidus, polyuria, and reduced concentrating ability.
C. 0.8-1.2 mmol/L (too high range) - Similar to option B, lithium toxicity is more likely to occur at concentrations above 1.2 mmol/L, associated with the side effects mentioned in option B.
D. 1.0-1.5 mmol/L (too high range) - As with options C and D, lithium toxicity is more likely to occur at concentrations above 1.5 mmol/L, resulting in the side effects mentioned above.
**Clinical Pearls:**
1. Regular monitoring of lithium levels is crucial in the initial phases of therapy to optimize therapeutic drug concentrations.
2. Lithium levels should be measured at least once a week during the first two to three months of treatment initiation and then less frequently (every 1-2 weeks) as the therapeutic range becomes more stable.
3. Lithium toxicity may be asymptomatic initially but can lead to serious complications later on, emphasizing the importance of regular monitoring and maintaining the therapeutic range.
4. Lithium is commonly used in the treatment of bipolar disorder and schizoaffective disorder, with a narrow therapeutic range to avoid toxicity.